Background: Herpes simplex virus type 2 (HSV-2) infectious disease is one of the most common viral sexually transmitted diseases. As regards, vaginal lactobacilli play an important role in protecting host against the urogenital pathogens; here we assessed the potential antiviral activity of Lactobacillus crispatus against HSV-2 infection in vitro. Methods: Both Vero and HeLa cell lines were treated by L. crispatus before, during and after HSV-2 infection. The pre-incubation assay was also performed for the evaluating of virus adsorption by L. crispatus. Virus titer reduction in each stage was determined by a plaque reduction assay. Results: L. crispatus significantly decreased the infectivity of the HSV-2 in initial steps on both cell lines; however, no significant inhibition was ascertained during adsorption and multiplication process. The lactobacilli adhere on Vero cells two-fold stronger than HeLa and subsequently protect the Vero cells nearly 2.5 fold higher than HeLa cell against the virion. Co-incubation of HSV-2 with bacterial cells prior to virus inoculation significantly decreased the virus titer. Conclusion: L. crispatus appears to inhibit the entry of the virus into cells by trapping HSV-2 particles. In addition, formation of L. crispatus microcolonies in the cell surface could block HSV-2 receptors and prevent viral entry to cells in initial infection steps.
Introduction
Herpes simplex virus (HSV-2) is a member of the herpesviridiae family and the principal species responsible for genital herpes.
1 HSV-2 produces localized lesions on skin and mucus membranes of infected individuals, predisposing partners to acquired HIV during sexual activity. 2 Several drugs, such as acyclovir, valacyclovir, and famciclovir are used to treat HSV-2. Resistance to the many of these drugs, especially acyclovir, has been increasingly reported. 3 Therefore, new strategies for prophylactic and treatment of HSV-2 infection are necessary.
It has been reported that any disturbance in the population of normal microbiota of the vagina gives rise to a risk of urogenital tract infections, such as bacterial vaginosis, candidiasis, and viral sexually transmitted diseases. 4, 5 Clinical studies have demonstrated that an abnormal vaginal flora is a risk factor for harboring HSV-2 and human papillomavirus (HPV) viruses. 6, 7 Lactobacilli are part of the vaginal microbiota of healthy females, 8 and several studies have investigated
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the inhibitory effect of different lactobacillus species against HSV, but the mechanism of action of lactobacilli in combating HSV infection remains unclear. 9e12 Numerous mechanisms have been proposed for the protection of the epithelial layer of the vagina against invasion pathogens. These include secreted bacterial metabolites (lactic acid, hydrogen peroxide, and bacteriocin), stimulation of innate immunity, and competition for epithelial cell receptors. 13, 14 One of the most important characteristics of lactobacilli is their ability to colonize epithelial and mucosal cells, thereby preventing invasion by pathogens of these cells. 15, 16 Lactobacilli might inhibit viral multiplication via competition for attachment to cell receptors or via induction of epithelial cells to produce antimicrobial substances. 17 Normal vaginal microbiota has been composed with more than 20 species of lactobacilli that their characteristics and proportions vary in different ethnic groups. 18 As regards, Lactobacillus crispatus is one of the dominant species colonized in the healthy female vagina; it would be interesting to verify inhibitory effect of this strain against HSV-2.
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The Vero cell line, derived from African green monkey kidney cells, is competent for the replication of many human viruses, including HSV-2. 20 In the present study, to understand the probable interference of lactobacilli with the viral infection in the human cells, HeLa cells, derived from human tissues was used, as well as Vero cells, to examine the potential role of L. crispatus in combatting HSV-2 infection.
Methods

Virus, cell lines and bacteria
HSV-2 strain was purchased from Tarbiat Modares University, Tehran, Iran. The virus was propagated in Vero and HeLa cell lines (provided from Razi institute, Iran). A titer of 10 7 PFU/ml of the virus was determined by a plaque assay, and viral particles with a multiplicity of infection (MOI) of 0.01 were used in all the experiments. Both Vero and HeLa cells were maintained in Dulbecco's Modified Eagles Medium (DMEM, Gibco-Germany), supplemented with 10% fetal bovine serum (Gibco-Germany) and 1% penicillin/streptomycin (Gibco-Germany) and incubated at 37 C with 5% CO 2 . Our previously reported isolate, L. crispatus KP090111, from the vagina of a healthy Iranian female was used as a probiotic candidate in this study. 21 The isolated bacterium was maintained in de Man Rogosa-Sharp (MRS, Merck-Germany) broth containing 20% glycerol at À70 C. Viable microorganisms were counted by plating serial 10-fold dilutions of the bacterial suspension on MRS agar after incubation for 48 h. Based on colony-forming units, the number of viable bacteria in 1 ml of the suspension after 24 h was determined as 10 8 CFU/ml. Using spectrophotometry, the optical density at this concentration was equal to 2.
Determination of the cytotoxicity of L. crispatus
To evaluate the possible cytotoxicity of the lactobacilli in the cell lines, a serial dilution of bacteria was prepared, and each dilution was added to a cell monolayer of both Vero and HeLa cells cultured on 96-well plates. The survival ability of the cells was determined by methylthiazolyl-diphenyltetrazolium bromide (MTT) assay. Briefly, bacterial cells from an overnight suspension culture of L. crispatus were collected and washed with Phosphate-buffered saline (PBS). The pellet was resuspended in DMEM without antibiotics at different concentrations (10 4 , 10 5 , 10 6 , 10 7 , and 10 8 CFU/ml). Then, 100 ml of each bacterial dilution was added to each well and the microplate was incubated at 37 C with 5% CO 2 for 24 h. Cells were then washed with PBS three times, and 180 ml of fresh DMEM and 20 ml of MTT (5 mg/ml) were added to each well and the plate was incubated at 37 C for 4 h. Finally, after addition of DMSO, an ELISA reader (Tekan-Germany) read the optical density (OD) at 570 nm. The percentage of cell viability was calculated according to the Kassaa et al. 12 Cells with DMEM were used as a negative control.
Adhesion of L. crispatus to Vero and HeLa cells
The ability of bacterium to attach to the target cells was determined as previously described. 21 Briefly, overnight culture of L. crispatus was collected, washed with PBS, and resuspended in DMEM to a final concentration of 10 8 CFU/ml. Then a bacterial suspension with CFU/cell ratio of 100 was added to the monolayer of target cells in 24 well-plates. After 4 h incubation at 37 C, the cell monolayer was washed with PBS three times to remove free bacteria from the well. The cells were detached from the well by trypsin 0.05% and resuspended in DMEM. The total number of viable bacteria adhered to the cells was determined by the colony counting method.
Antiviral activity of the bacterial supernatant
Overnight culture of L. crispatus was washed in PBS and 5 Â 10 6 CFU resuspended in DMEM. The suspension was maintained at 37 C for 24e48 h. The bacterial suspension was then centrifuged for 10 min at 10,000 g at 4 C, the supernatant was collected, and the pH was neutralized with NaOH 1M in a sterile condition.
In vitro interference experiments
For interference studies, infection of the Vero and HeLa cells (concentration of 10 5 cells/well) with HSV-2 was performed at a MOI of 0.01. The suspension of L. crispatus was applied to the cell culture, at a concentration of 10 7 CFU/ml (100 CFU/cell), in three different stage of the HSV-2 life cycle that let us to know at which step during viral cycle, the addition of the lactobacillus is most effective. In the first series of the experiment, named pre-treatment, the cells were treated first with a suspension of L. crispatus for 1.5 h, and then supplemented with HSV-2 for 1 h. In second series of the experiments, named competition, the cells were concurrently exposed to the bacterium and HSV-2 for 1 h; they were also first exposed to the virus for 1 h and then to the bacteria without washing in the third series of experiments so called post-infection. The schematic representation of our experimental setup for studying the interference was depicted in Supplementary Fig. 1 . After 24 h incubation of the cells at 37 C, the supernatant of each well was collected and titered for infectivity of HSV-2 on Vero and HeLa cells by plaque reduction assay.
In another experiment, named pre-incubation (See S Fig. 1) , direct interaction between bacteria and the virus particles in a cell free system was evaluated. Briefly, a microtube containing the lactobacilli and viral particles was incubated for 2 h at room temperature. The microtube was then centrifuged for 10 min at 4000 g and the supernatant was subjected to the aforementioned plaque assay analysis. All experiments were performed in triplicate for a minimum of six wells.
Plaque reduction assay
The titer of the virus was determined by plaque assay. Nearly, 4 Â 10 5 cells/well were seeded in six well plates and incubated for 24e48 h to reach at least 98% of confluence. The collected supernatants were serially diluted and 500 ml of each dilution were added to each well. The plate was incubated at 37 C for 1 h to allow attachment of the virus to the cells. The supernatant was then removed from each well, and 3 ml of 1.5% DMEM/agar was added to each well. The plates were incubated for 48e72 h until the formation of plaques. Neutral red at a concentration of 0.01 was added to each well and incubated for 24 h. The plaques were then counted. A reduction in the number of plaques in each experiment was determined by comparison with a positive control (a suspension of the viruses with MOI of 0.01).
Statistical analysis
All calculations were performed with IBM SPSS software, version 22. ANOVA, followed by a Least Significant Difference (LSD) test that performed to compare the reduction in the viral titer in each of the experiments. The P value of <0.05 was considered statistically significant. All the data are given as the mean ± SD.
Results
Evaluation of the L. crispatus effect on the cell viability and its capability to attachment to the cells
Based on the cytotoxicity assay of L. crispatus on Vero and HeLa cells, the cell viability was dramatically decreased when the concentration of lactobacilli raised from 10 7 CFU/ml to 10 8 CFU/ml (Fig. 1) . Thereby, an optimum concentration of 10 7 CFU/ml was applied in all the interference experiments. The bacterial adhesion was measured after 2 h coincubation of the bacteria and both Vero and HeLa cells. As shown in Fig. 2 the results were expressed as a percentage of the initial bacterial count. 22 The percentage of adhering bacteria to Vero and HeLa cells was 12% (SD ¼ 2.5) and 5.8% (SD ¼ 1.2) respectively.
Evaluation of virus titer reduction in the cells treated with L. crispatus
As delineated in Fig. 3 , amongst the three interference experiments, a significant antiviral activity of the L. crispatus was shown in the pre-treatment step on both Hela and Vero cells. But, the titer of HSV-2 was more decreased in the Vero than HeLa cell line. However, in the both cell lines, neither in competition stage, when virus and bacteria simultaneously were presented on cells, nor in post-infection, which bacteria were added after adsorption of the virus into the cells, there was no significant reduction in the HSV-2 titer.
Virus adsorption by the bacteria in pre-incubation assay
The analysis of HSV-2 adsorption by L. crispatus showed that the virus titer of the supernatant was dramatically decreased after 2 h incubation of the bacteria and the viruses in a cell free condition (Fig. 3) . 
Antiviral activity of the bacterial supernatant
No significant changes in the virus infectivity were observed after 2 h co-incubation of the bacterial supernatant and the HSV-2 at room temperature on both Vero and HeLa cell lines (Fig. 4) .
Discussion
HSV-2 is one of the most prevalent etiologies of sexually transmitted diseases, a risk factor for acquiring HIV. 23 Clinical and animal studies have demonstrated that lactobacilli play an important role in the prevention of viral infections. 24 Vaginal microbiota inhibits the viral infection by several postulated mechanisms such as production of active metabolites, formation physical barrier against pathogen adhesion on epithelial cells, 24 physical interaction to the virus envelope 12, 25 and stimulation of the immune system. 26 In this study, we assessed the potential anti-HSV activity of L. crispatus, which is one of the most dominant lactobacillus species isolated from healthy women vagina. 21, 27 It has been shown that pre-treatment of Lactobacillus gasseri strain on Vero cells dramatically inhibited the infectivity of HSV 1 & 2.
11,12 Consistently, on HeLa and Vero cell lines, L. crispatus significantly decreased the infectivity of the virion in initial steps by 26e49%, respectively (Fig. 3) . However, presence of the metabolically active bacterial cells during or after infection process have the same results as control (Fig. 3) . As previously reported co-incubation of the bacteria and HSV-2 at the CFU/PFU ratio of 1e100,000 on cells resulted varied range of inhibition from 0 to 90%. 10, 12 Similarly, our results showed that virus particles adsorbed more effectively than bacteria on cell membrane but antiviral activity increased when the PFU/CFU ratio reduced from 10 to 1 (data not shown). Also after entry of the virus particles to the cells no further inhibition was induced by the lactobacilli on intracellular virus replication process (Fig. 3) . Overall, these results suggested that physical interaction or active metabolites of the lactobacilli inhibit/block the adsorption of HSV-2 to the cell membrane. 10, 24, 28 Some studies have shown that the excretion of metabolites, such as lactic acid, bacteriocin and H 2 O 2 , by lactobacilli was contributed in the inactivation of HSV particles before infection.
10,11 So, we examined the antiviral activity of the L. crispatus secreted metabolites as described by previous studies. 10, 12 No significant antiviral activity was found in the supernatant when the bacteria were grown in DMEM media (Fig. 4) . On the contrary, co-incubation of HSV-2 with bacterial cells prior to virus inoculation significantly decreased the virus titer by up to 60% (Fig. 3) . In this concept, Lai et al. demonstrated that vaginal lactobacilli attachment to the surface of HIV prevented the diffusion stage of this virus. 29 Ivec et al. reported that lactobacilli were able to block virus entry into cells by trapping the VSV particles. 25 Kassa et al. also obtained similar results for the inactivation of HSV-2 particles with attachment of L. gasseri to viral envelope. 12 These findings are in line with the possibility of virus inactivation with physical interaction between lactobacilli and viral envelope. 30 Besides, as shown in Fig. 3 the inhibitory effect of the L. crispatus on the Vero cells was approximately 2.5 fold higher than HeLa in initial infection steps. This may be described by nearly two-fold stronger adherence of L. crispatus to Vero cell line (Fig. 2) . The first step of virus entry to a host cell is virus attachment to the cell receptors, and therefore inhibition of this attachment could be prevent disease process. 33 Lactobacilli may block virus entry to the host cell by masking specific or non-specific receptors. 15, 28 Therefore, the second possibility of virus inactivation by L. crispatus is thought to be exerted through a physical barrier that formed by the bacterial cells on cell membrane. 28, 30 The capability of lactobacilli to attach to the cells depends on various factors like the cell wall components of bacteria, cell receptors and soluble proteins secreted by the host cells. 31 Moreover, previous studies indicated that L. crispatus strains encode adhesion components named, S-layer proteins that play important role on adherence of bacteria on Hela cells. 32 However, more studies should be conducted on normal vaginal cell lines to elucidate the adhesion ability of lactobacilli on epithelial cells and protection against viral infections.
In conclusion, two mechanisms may be involved in the antiviral effect of lactobacilli towards HSV-2 (1.) formation of L. crispatus microcolonies in the cell surface could block HSV-2 receptors and prevent viral entry to cells in initial infection steps and (2.) entrapment of viral particles by direct interaction of L. crispatus with HSV-2 envelope.
Since the present results indicate a physical contact between bacterial cells and viral envelope could inhibit HSV-2 infection, it would be interesting to examine the potential prophylactic properties of L. crispatus cell wall components against HSV-2 infection in vitro and in vivo.
